# A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-1-2-trial-of-an-immune-modulatory-vaccine-against-ido-pd-l1-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Julie Westerlin Kjeldsen,Cathrine Lund Lorentzen,Evelina Martinenaite,Eva Ellebæk,Marco Donia,Rikke Boedker Holmstroem,Tobias Wirenfeldt Klausen,Cecilie Oelvang Madsen,Shamaila Munir Ahmed,Stine Emilie Weis-Banke,Morten Orebo Holmström,Helle Westergren Hendel,E. Ehrnrooth,Mai-Britt Zocca,Ayako Wakatsuki Pedersen,Mads Hald Andersen,Inge Marie Svane |
| Citations | 213 |
| DOI | 10.1038/s41591-021-01544-x |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41591-021-01544-x.pdf |
| OpenAlex ID | https://openalex.org/W4200495164 |
| PMID | 34887574 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Tobias Wirenfeldt Klausen](https://scholariq.org/researchers/tobias-wirenfeldt-klausen/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.